Generic drugs are of the same chemical composition as that of the branded drugs, yet considerably low-priced. Drugs not covered by a patent are prone to be overtaken by their generic counterparts in due course. The latter, of course, is benefitted by the promotional samples and marketing strategies of the brands. End consumers find this economical and available off-counter, hence, making it the preferred version over time. The reports by Big Market Research in the Generic Drugs segment provide a quantitative analysis of the market structure and areas of growth for the industry players. Trends of recent past, the factors hampering new entrants, and key financial activities by lead players present a fair forecast of growth projections for next half of the decade.
No of Reports 0